Investor Presentaiton

India Business - Sales ramp-up Leadership in chronic segment; Strong positioning in acute segment 32 brands in top 300 brands of country Sales in Rs Billion Therapeutic Revenue Break-up 15 20 20 10 year CAGR 18% 17 24 29 30 30 37 67 71 77 80 50 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 © Sun Pharmaceutical Industries Limited. All Rights Reserved. Others Opthalmology 2% 6% Respiratory 4% Cardiology 18% Vitamins/ Minerals / SUN PHARMA Nutrients, 4% Gynaecology, 4% Dermatology, 6% Market Share 8.5% Neuro-Psychiatry 18% Pain Analgesics 7% Diabetology, 9% Anti-Infectives 10% Gastroenterology 12% • As per AIOCD AWACS – March '18 23

View entire presentation